121 related articles for article (PubMed ID: 31216333)
1. Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study.
Katanga J; Kjaer SK; Manongi R; Wu CS; Iftner T; Waldstrom M; Pembe AB; Mwaiselage J; Rasch V
PLoS One; 2019; 14(6):e0218559. PubMed ID: 31216333
[TBL] [Abstract][Full Text] [Related]
2. Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
Katanga J; Kjaer SK; Manongi R; Pembe AB; Iftner T; Waldstrom M; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):786-793. PubMed ID: 33497480
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
4. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in China.
Wang M; Hu S; Zhao S; Zhang W; Pan Q; Zhang X; Chen F; Han J; Ma J; Smith JS; Qiao Y; Zhou C; Zhao F
Chin J Cancer Res; 2017 Dec; 29(6):496-509. PubMed ID: 29353972
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda.
Umulisa MC; Franceschi S; Baussano I; Tenet V; Uwimbabazi M; Rugwizangoga B; Heideman DAM; Uyterlinde AM; Darragh TM; Snijders PJF; Sayinzoga F; Clifford GM
BMC Womens Health; 2018 Apr; 18(1):59. PubMed ID: 29699549
[TBL] [Abstract][Full Text] [Related]
7. The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens.
Chen W; Jeronimo J; Zhao FH; Qiao YL; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
J Clin Virol; 2014 Dec; 61(4):553-7. PubMed ID: 25453572
[TBL] [Abstract][Full Text] [Related]
8. A parallel study of careHPV and Hybrid Capture 2 human papillomavirus DNA testing for cervical cancer screening in rural China.
Lin CQ; Chen F; Liu B; Zhang YZ; Cui XL; Li AM; Zhang WH; Chen W; Chang I; Sivasubramaniam P; Zhu J; Qiao YL
J Virol Methods; 2014 Jun; 202():73-8. PubMed ID: 24642241
[TBL] [Abstract][Full Text] [Related]
9. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
Ding Z; Li Y; Chen A; Song M; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
[TBL] [Abstract][Full Text] [Related]
12. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
13. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
14. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
[TBL] [Abstract][Full Text] [Related]
16. CareHPV cervical cancer screening demonstration in a rural population of north India.
Labani S; Asthana S; Sodhani P; Gupta S; Bhambhani S; Pooja B; Lim J; Jeronimo J
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():75-9. PubMed ID: 24685404
[TBL] [Abstract][Full Text] [Related]
17. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
Labani S; Asthana S
J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
[TBL] [Abstract][Full Text] [Related]
18. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
[TBL] [Abstract][Full Text] [Related]
20. [Cost-effectiveness analysis on the once-in-a-lifetime cervical cancer screening program for women living in rural and urban areas of China].
Xu H; Zhao FH; Gao XH; Hu SY; Chen JF; Liu ZH; Xu XL; Gao LM; Liu QG; Ma L; Liu YJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Apr; 34(4):399-403. PubMed ID: 23937850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
